# Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?

> **NCT02276495** · NA · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 55 (actual)

## Conditions studied

- Pain Management

## Interventions

- **OTHER:** ACB Control - 20 ml saline injection for ACB
- **DRUG:** ACB Study - 20 ml 0.5% Ropivacaine for Adductor Canal Block
- **DRUG:** Local infiltration - 100 mLs of a solution containing: Ropivacaine + Epinephrine + Ketorolac + Clonidine + 0.9% Normal saline

## Key facts

- **NCT ID:** NCT02276495
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2020-06-20
- **Final completion:** 2024-09-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2024-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02276495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02276495, "Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02276495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*